22:24:42 EDT Fri 04 Sep 2026
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Theralase Technologies Inc
Symbol TLT
Shares Issued 257,058,334
Close 2026-09-04 C$ 0.185
Market Cap C$ 47,555,792
Recent Sedar+ Documents

Theralase private placement, warrant listing

2026-09-04 21:00 ET - Private Placement

Financing type:  brokered private placement (LIFE (listed issuer financing exemption) offering)

Gross proceeds:  $3,555,000

Offering:  14,812,500 units (Each unit comprised one listed share and one warrant.)

Offering price:  24 cents per unit

Warrant exercise terms:  32 cents per listed share until May 20, 2031

Commissions in securities:  The broker received 903,723 broker warrants for services rendered.

Broker warrants:  903,723 (one broker)

Broker warrant terms:  Each broker warrant is non-transferable and exercisable into one unit at 24 cents until May 20, 2031.

Additional listing of warrants (TLT.WT)

Further to the TSX Venture Exchange bulletins dated June 5, 2026, and Sept. 4, 2026, up to 15,716,223 additional listed warrants (Cusip No. 88337V 14 2) of the company have been authorized for issuance pursuant to a supplemental warrant indenture dated Aug. 24, 2026.

Revised capitalization:  up to 36,115,273 warrants, authorized by a warrant indenture dated May 20, 2026, and supplemented by a first supplemental warrant indenture dated Aug. 24, 2026, of which 33,979,167 warrants are issued and outstanding

Disclosure:Refer to the offering document dated Aug. 10, 2026, and the company's news releases dated Aug. 10, 2026, and Aug. 24, 2026.

© 2026 Canjex Publishing Ltd. All rights reserved.